A Configurationally Stable Chiral Concave Imidazolinium Salt
ν = 3344 (N–H), 3076 (=C–H), 2933, 2872 (aliph. C–H), 1696
triethyl orthoformate (5 mL) and stirred for 1 h at 140 °C. After
evaporation of the solvent, the product was purified by column
chromatography [silica gel, dichloromethane/methanol (10:1), Rf =
0.36]. A white solid (614 mg, 952 μmol, 96%) was obtained. M.p.
153–154 °C. 1H NMR (500 MHz, CDCl3, 300 K): δ = 8.21 (s, 1 H,
2-Him), 7.96 (d, J = 9.0 Hz, 1 H, 5-Hnaph), 7.80 (d, J = 9.0 Hz, 1
H, 4-Hnaph), 7.37 (t, 3J = 8.5 Hz, 1 H, 4-Hph), 7.23 (d, 3J = 9.0 Hz,
1 H, 3-Hnaph), 7.14 (dd, 3J = 9.0 Hz, 4J = 2.3 Hz, 1 H, 6-Hnaph),
˜
(C=O), 1628, 1598, 1505 (arom. C=C), 1257, 1213 (=C–O), 1097,
1056 (O–CH2), 992, 909 (alkenyl = C–H), 825 (1,2,7-trisubst. naph
C–H) cm–1. MS (EI, 70 eV): m/z (%) = 640 (13) [M]+, 352 (100)
[C23H30NO2]+. MS (CI, isobutane): m/z (%) = 641 (83) [M]+, 352
(35) [C23H30NO2]+, 332 (100) [C20H30NO3]+, 312 (76) [C20H26-
NO2]+, 352 (35) [C23H30NO2]+, 352 (35) [C23H30NO2]+.
C40H54N2O4 (640.85): calcd. C 74.48, H 8.18, N 4.44; found C
74.66, H 8.61, N 4.14.
3
3
4
3
7.09 (d, J = 2.3 Hz, 1 H, 8-Hnaph), 6.68 (d, J = 8.5 Hz, 2 H, 3-
3
3
3
H
ph, 5-Hph), 5.86 [ddt, JZ = 17.0 Hz, JE = 10.3 Hz, J = 6.7 Hz,
2-[2,7-Bis(pent-4-enyloxy)naphthylamino]-3-[2,6-bis(pent-4-enyloxy)-
phenylamino]-2-methylpropane (16): Lithium aluminum hydride
(604 mg, 15.9 mmol) was suspended in dry tetrahydrofuran
(40 mL). At 0 °C, a solution of amino propanamide 15 (2.04 g,
3.18 mmol) in dry tetrahydrofuran (60 mL) was added slowly.
Then, the mixture was heated at reflux for 16 h. After cooling to
room temperature, the suspension was poured into ice water
(100 mL), and the aqueous layer was extracted with tert-butyl
methyl ether (3ϫ80 mL). After evaporation of the solvent, the
product was purified by column chromatography [silica gel, cyclo-
hexane/ethyl acetate (14:1), Rf = 0.37]. A reddish oil (1.59 g,
2.54 mmol, 80%) was obtained. 1H NMR (500 MHz, CDCl3,
300 K): δ = 7.76 (d, 4J = 2.2 Hz, 1 H, 8naph-H), 7.60 (d, 3J = 8.9 Hz,
1 H, 5naph-H), 7.48 (d, 3J = 8.9 Hz, 1 H, 4naph-H), 7.06 (d, 3J =
8.9 Hz, 1 H, 3naph-H), 6.93 (dd, 3J = 8.9 Hz, 4J = 2.2 Hz, 1 H,
3
3
1 H, 7naph-O(CH2)3CH], 5.79 [ddt, JZ = 17.0 Hz, JE = 10.3 Hz,
3J = 6.7 Hz, 1 H, 2naph-O(CH2)3CH], 5.76 [ddt, 3JZ = 17.6 Hz, JE
3
= 9.7 Hz, 3J = 6.6 Hz, 2 H, 2ph-O(CH2)3CH, 6ph-O(CH2)3CH], 5.07
3
2
4
[ddt, JZ = 17.0 Hz, J = 1.8 Hz, J = 1.6 Hz, 1 H, 7naph-O(CH2)3-
CHCHEHZ], 5.03–4.94 [m, 7 H, 2naph-O(CH2)3CHCH2, 7naph
O(CH2)3CHCHEHZ, 2ph-O(CH2)3CHCH2, 6ph-O(CH2)3CHCH2],
-
3
3
4.64 (d, J = 11.4 Hz, 1 H, 5-Him,a), 4.35 (d, J = 11.4 Hz, 1 H, 5-
Him,b), 4.22 (mc, 2 H, 2naph-OCH2), 4.16–4.05 (m, 6 H, 7naph-OCH2,
2ph-OCH2, 6ph-OCH2), 2.29 [dt, 3J = 7.9 Hz, 3J = 6.7 Hz, 2 H,
2
naph-O(CH2)2CH2], 2.23–2.17 [m, 6 H, 7naph-O(CH2)2CH2, 2ph
-
-
O(CH2)2CH2, 6ph-O(CH2)2CH2], 2.00–1.90 (m, H, 2naph
8
OCH2CH2, 7naph-OCH2CH2, 2ph-OCH2CH2, 6ph-OCH2CH2), 1.74
(s, 3 H, CH3), 1.67 (s, 3 H, CH3) ppm. 13C NMR (125 MHz,
CDCl3, 300 K): δ = 161.3 (d, C-2im), 159.3 (s, C-7naph), 154.5 (s,
C-2ph, C-6ph, C-2naph),* 137.6 [d, =CH(CH2)3OC-7naph], 137.0 [d,
=CH(CH2)3OC-2naph], 136.9 [d, =CH(CH2)3OC-2ph, =CH(CH2)3-
OC-6ph], 133.7 (s, C-8anaph), 132.8 (d, C-5naph), 131.6 (d, C-4ph),
130.6 (d, C-4naph), 124.5 (s, C-4anaph), 116.7 (d, C-6naph), 115.8 [t,
3
3
6
naph-H), 6.71 (t, J = 8.2 Hz, 1 H, 4ph-H), 6.53 (d, J = 8.2 Hz, 2
H, 3ph-H, 5ph-H), 5.89–5.76 [m, 2 H, 2naph-O(CH2)3CH, 7naph-O-
3
3
3
(CH2)3CH], 5.73 [ddt, JZ = 17.0 Hz, JE = 10.3 Hz, J = 6.8 Hz,
2 H, 2ph-O(CH2)3CH, 6ph-O(CH2)3CH], 5.08–4.93 [m, 4 H, 2naph
-
CH2CH(CH2)3OC-2ph
,
CH2CH(CH2)3OC-6ph],
115.8
[t,
O(CH2)3CHCH2, 7naph-O(CH2)3CHCH2], 4.90 [mc, 4 H, 2ph
-
CH2CH(CH2)3OC-2naph], 115.4 [t, CH2CH(CH2)3OC-7naph], 112.6
(s, C-1naph), 112.2 (s, C-1ph), 110.6 (d, C-3naph), 105.3 (d, C-3ph, C-
3
O(CH2)3CHCH2, 6ph-O(CH2)3CHCH2], 4.08 (t, J = 6.5 Hz, 2 H,
2naph-OCH2), 3.98 (t, 3J = 6.4 Hz, 4 H, 2ph-OCH2, 6ph-OCH2), 3.92
5
ph), 102.0 (d, C-8naph), 72.1 (s, C-4im), 68.9 (t, CH2OC-2naph), 68.5
(t, CH2OC-2ph, CH2OC-6ph), 67.5 (t, CH2OC-7naph), 63.6 (t, C-
5im), 30.1 [t, CH2(CH2)2OC-7naph], 30.0 [t, CH2(CH2)2OC-2ph
CH2(CH2)2OC-6ph], 30.0 [t, CH2(CH2)2OC-2naph], 28.4 (t,
CH2CH2OC-7naph), 28.3 (t, CH2CH2OC-2naph, CH2CH2OC-2ph
CH2CH2OC-6ph),* 27.3 (q, CH3), 25.9 (q, CH3) ppm; *signals
3
3
(t, J = 6.4 Hz, 2 H, 7naph-OCH2), 3.45 (s, 2 H, NCH2), 2.27 [q, J
3
= 7.1 Hz, 2 H, 2naph-O(CH2)2CH2], 2.19 [q, J = 7.2 Hz, 4 H, 2ph
O(CH2)2CH2, 6ph-O(CH2)2CH2], 2.08 [q, J = 7.2 Hz, 2 H, 7naph
O(CH2)2CH2], 1.84 (quint., J = 6.9 Hz, 4 H, 2ph-OCH2CH2, 6ph
OCH2CH2), 1.94 (quint., J = 6.9 Hz, 2 H, 2naph-OCH2CH2), 1.73
(quint., 3J = 6.9 Hz, 2 H, 7naph-OCH2CH2), 1.16 (s, 6 H, CH3)
ppm; no NH signals observed. 13C NMR (125 MHz, CDCl3,
300 K): δ = 157.3 (s, C-7naph), 152.0 (s, C-2naph), 150.1 (s, C-2ph),
-
-
-
,
3
3
,
3
overlaid respectively. IR (ATR): ν = 3077 (=C–H), 2977, 2938,
˜
2873, 2841 (aliph. C–H), 1625, 1599 (arom. C=C), 1259, 1217 (=C–
O), 1096, 1060 (O–CH2), 990, 906 (alkenyl = C–H), 830 (1,2,7-
trisubst. naph C–H), 779 (1,2,3-trisubst. ph C–H) cm–1. MS (ESI,
CHCl3/MeOH): m/z (%) = 637 (100) [M – Cl]+. C41H53ClN2O4
138.5 [d, =CH(CH2)3OC-7naph], 138.2 [d, =CH(CH2)3OC-2ph
,
=CH(CH2)3OC-6ph], 138.1 [d, =CH(CH2)3OC-2naph], 135.2 (s, C-
8anaph), 129.6 (s, C-1ph), 129.3 (d, C-4naph), 128.9 (s, C-1naph), 125.3
(s, C-4anaph), 124.6 (d, C-5naph), 118.8 (d, C-4ph), 117.2 (d, C-6naph),
(673.32): calcd.
C 73.14, H 7.93, N 4.16; C41H53ClN2O4·
0.5CH3OH: calcd. C 72.31, H 8.04, N 4.06; found C 72.07, H 8.31,
N 4.40.
115.6 [t, CH2CH(CH2)3OC-2naph], 115.4 [t, CH2CH(CH2)3OC-2ph
,
CH2CH(CH2)3OC-6ph], 115.1 [t, CH2CH(CH2)3OC-7naph], 111.2
(d, C-3naph), 106.4 (d, C-3ph, C-5ph), 104.2 (d, C-8naph), 68.4 (t,
CH2OC-2naph, CH2OC-2ph, CH2OC-6ph)*, 67.4 (t, CH2OC-7naph),
58.6 [s, C(CH3)2], 58.3 (t, NCH2), 30.7 [t, CH2(CH2)2OC-2naph],
30.6 [t, CH2(CH2)2OC-2ph, CH2(CH2)2OC-6ph], 30.5 [t, CH2(CH2)2-
2,11,13,22-Tetraoxa-1(1,3,2)-benzena-12(2,7,1)-naphthalena-
23(1,3)-4,4-dimethylimidazoliuminabicyclo[10.10.1]tricosaphane-
6,17-diene Chloride (18): Tetraene 17 (433 mg, 643 μmol) and
benzylidenebis(tricyclohexylphosphane)dichlororuthenium
(52.9 mg, 64.3 μmol) were dissolved in dry dichloromethane
(500 mL), and the mixture was stirred for 24 h at room tempera-
ture. Then, ethyl vinyl ether (1 mL) was added, and the mixture
was stirred for 1 h. After evaporation of the solvent, the product
was purified twice by column chromatography [silica gel, dichloro-
methane/methanol (10:1), Rf = 0.42]. A white solid (350 mg,
567 μmol, 88%) was obtained. M.p. 147–150 °C. 1H NMR
(500 MHz, CDCl3, 300 K): δ = 8.22 (s, 0.2 H, 2-Him), 8.11 (s, 0.7
H, 2-Him), 8.02 (s, 0.1 H, 2-Him), 7.94 (d, 3J = 9.1 Hz, 1 H, 4-
Hnaph), 7.79 (d, 3J = 9.7 Hz, 1 H, 5-Hnaph), 7.36 (t, 3J = 8.5 Hz, 0.2
OC-7naph], 29.2 (t, CH2CH2OC-2naph), 29.1 (t, CH2CH2OC-2ph
,
CH2CH2OC-6ph), 28.9 (t, CH2CH2OC-7naph), 27.1 (q, CH3) ppm;
*signals overlaid. IR (ATR): ν = 3356 (N–H), 3076 (=C–H), 2937,
˜
2870 (aliph. C–H), 1627, 1597 (arom. C=C), 1255, 1214 (=C–O),
1095, 1055 (O–CH2), 991, 909 (alkenyl = C–H), 824 (1,2,7-trisubst.
naph C–H) cm–1. MS (ESI, CHCl3/MeOH): m/z (%) = 627 (100)
[M + H]+, 316 (35) [C20H30NO2]+. C40H54N2O4 (626.41): calcd. C
76.64, H 8.68, N 4.47. C40H54N2O4·0.25H2O: calcd. C 76.09, H
8.70, N 4.44; found C 76.05, H 8.56, N 4.63.
3-[2,7-Bis(pent-4-enyloxy)naphthyl]-1-[2,6-bis(pent-4-enyloxy)-
phenyl]-4,4-dimethyl-4,5-imidazolinium Chloride (17): To a solution
of diamine 16 (618 mg, 986 μmol) in dry dichloromethane (5 mL)
was added HCl (4 m in 1,4-dioxane, 1 mL). After stirring for
10 min, the solvent was evaporated. The residue was dissolved in
3
3
H, 4-Hph), 7.35 (t, J = 8.5 Hz, 0.1 H, 4-Hph), 7.34 (t, J = 8.5 Hz,
3
3
0.7 H, 4-Hph), 7.25 (d, J = 9.1 Hz, 0.2 H, 3-Hnaph), 7.24 (d, J =
9.1 Hz, 0.7 H, 3-Hnaph), 7.21 (d, 3J = 9.1 Hz, 0.1 H, 3-Hnaph), 7.14–
4
7.09 (m, 1.8 H, 6-Hnaph, 8-Hnaph), 7.05 (d, J = 2.4 Hz, 0.2 H, 8-
Eur. J. Org. Chem. 2011, 1040–1046
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1045